INTRODUÇÃO: O tratamento com ondas de choque (TOC) é utilizado para tratar numerosas afecções musculoesqueléticas, incluindo-se as pseudartroses e as tendinopatias. Há poucos estudos bem estruturados sobre a eficácia do TOC no tratamento da síndrome dolorosa miofascial (SDM) e não há ensaio clínico aleatorizado sobre sua utilização no tratamento das SDMs das regiões lombar e glútea. OBJETIVOS: Avaliar a eficácia do TOC no tratamento das SDMs das regiões lombar e glútea. CASUÍSTICA E MÉTODOS: Foi realizado estudo prospectivo, controlado, com amostra aleatória e duplamente encoberto sobre o tratamento de doentes com dor moderada a intensa decorrente de SDM nas regiões lombar e glútea com duração superior a seis meses, submetidos previamente a tratamento padronizado com antidepressivo, analgésico, terapia física e orientações fisioterápicas durante seis semanas. Foram elegíveis 46 doentes que apresentavam dor com intensidade >= 4 de acordo com a EVA dentre os 121 convocados. Durante seis semanas os doentes elegíveis foram submetidos a tratamento farmacológico e fisioterápico padronizado. Sete doentes usufruíram melhora clínica importante e oito abandonaram o estudo, restando 31 doentes que participaram efetivamente do estudo. Após a randomização, 14 doentes foram submetidos a TOC com cabeçote ativo e 17 a TOC com cabeçote placebo. Foram avaliados os aspectos demográficos, a apresentação clínica, a incapacidade funcional, a intensidade e as características da dor até um ano após a realização dos procedimentos destes 31 doentes. As avaliações foram realizadas com uso da Escala Visual Analógica (EVA), Questionário de Incapacidade de Roland-Morris (RDQ), Índice de Incapacidade de Oswestry (ODI), Versão Reduzida do Questionário de Dor McGill (SF-MPQ) e Inventário Diagnóstico da Dor Neuropática 4 (DN4). RESULTADOS: Não houve diferenças estatisticamente significativas entre os grupos quanto às características sociodemográficas dos doentes. Entretanto, a duração das queixas de dor dos doentes do grupo TOC ativo foi significativamente superior (p < 0,05) a dos do grupo TOC placebo. Em relação aos doentes tratados com TOC placebo, os doentes tratados com TOC ativo usufruíram redução estatisticamente significativa da dor de acordo com a EVA na interação grupo versus tempo a partir do momento \"três meses\"; a melhora manteve-se estatisticamente significativa durante um ano (p < 0,001), achado que sugere que o efeito analgésico instala-se em longo prazo e mantém-se prolongadamente. Não ocorreu modificação estatisticamente significativa na interação grupo versus tempo nas pontuações dos questionários RDQ, ODI e SF-MPQ ao longo do tempo nos doentes de ambos grupos. No momento \"12 meses\" ocorreu redução superior a 50% da incapacidade funcional da dor lombar avaliada de acordo com o RDQ em 70,0% dos doentes do grupo TOC ativo e em apenas 14,3% dos doentes tratados com TOC placebo; diferença percentual estatisticamente significativa (p < 0,05). Ocorreu também redução superior a 50% das pontuações do ODI na avaliação realizada no momento \"12 meses\" em 70,0% dos doentes incluídos no grupo TOC ativo e em apenas 14,3% dos doentes do grupo TOC placebo, diferença percentual estatisticamente significativa (p < 0,05). CONCLUSÕES: O tratamento com o TOC ativo dos doentes com SDM nas regiões lombar e glútea proporcionou melhora significativa da dor a partir do momento \"três meses\" até, pelo menos, o momento \"12 meses\" de acompanhamento, achado que sugere que seu efeito analgésico instala-se tardiamente. Adicionalmente, proporcionou melhora da funcionalidade de acordo com o RDQ e ODI na avaliação realizada no momento \"12 meses\" / INTRODUCTION: Extracorporeal shockwave therapy (ESWT) has been used successfully in different musculoskeletal conditions, including pseudarthrosis and tendinopathies. However, there are very few well-structured studies on the efficacy of ESWT in the treatment of myofascial pain syndromes (MPSs) and no randomized clinical trial about the ESWT in the treatment of lumbar and gluteal myofascial pain. OBJECTIVES: To assess the efficacy of ESWT in the treatment of lumbar and gluteal MPSs. MATERIAL AND METHODS: The study was prospective, randomized, double-blind and placebo-controlled. From 121 patients with moderate or severe pain due to MPS in the lumbar and gluteal regions lasting more than six months were enrolled; a total of 46 patients with pain intensity >= 4 according to the VAS were considered eligible. The elected patients were treated with antidepressant, analgesic and physical therapy as a standard protocol during six weeks. Seven patients had significant clinical improvement with the pharmacological and physical therapies and eight dropped out the study. The remainder 31 patients were randomized and 14 underwent active ESWT and 17 underwent placebo ESWT. The demographic aspects, clinical presentations, functional disabilities, severity and characteristics of pain were evaluated previously to the inclusion in the study until the end of the first year after the treatment with active or placebo ESWT. The evaluations were based on the Visual Analogue Scale (VAS), Roland- Morris Disability Questionnaire (RDQ), Oswestry Disability Index (ODI), Short- Form of the McGill Pain Questionnaire (SF-MPQ), and the Neuropathic Pain Diagnostic Questionnaire 4 (DN4). RESULTS: There were no statistical differences between the groups regarding the baseline characteristics of the patients. However, the duration of pain of the patients treated with active ESWT was significantly higher (p < 0,05) than those treated with placebo ESWT. There was no statistically significant variation over time in the RDQ, ODI and SF-MPQ scores between the patients from each group. Patients treated with active ESWT presented a significant reduction of pain severity according to the VAS from the third until the 12nd month of follow-up (p < 0,001), finding indicative that the analgesic effect of the ESWT starts late but remains over time. At the 12nd month of follow-up, 70,0% of the patients treated with active ESWT and just 14.3% of the patients from de placebo ESWT group had more than 50% improvement of the functional disability of the low back pain according to the RDQ, statistically significant difference (p < 0,05). There was also a reduction of more than 50% of ODI scores in the 12th month of follow-up in 70.0% of the patients treated with active ESWT and in only 14.3% of the patients treated with placebo ESWT (p < 0,05). CONCLUSIONS: The active ESWT provided a significant and lasting reduction in pain intensity from the third until the 12th month of follow-up, finding that suggests that its analgesic effect settles late and has long duration. Additionally, it provided improvement of the functionality according to the RDQ and ODI at the 12th month of follow-up

INTRODUÇÃO: O tratamento com ondas de choque (TOC) é utilizado para tratar numerosas afecções musculoesqueléticas, incluindo-se as pseudartroses e as tendinopatias. Há poucos estudos bem estruturados sobre a eficácia do TOC no tratamento da síndrome dolorosa miofascial (SDM) e não há ensaio clínico aleatorizado sobre sua utilização no tratamento das SDMs das regiões lombar e glútea. OBJETIVOS: Avaliar a eficácia do TOC no tratamento das SDMs das regiões lombar e glútea. CASUÍSTICA E MÉTODOS: Foi realizado estudo prospectivo, controlado, com amostra aleatória e duplamente encoberto sobre o tratamento de doentes com dor moderada a intensa decorrente de SDM nas regiões lombar e glútea com duração superior a seis meses, submetidos previamente a tratamento padronizado com antidepressivo, analgésico, terapia física e orientações fisioterápicas durante seis semanas. Foram elegíveis 46 doentes que apresentavam dor com intensidade >= 4 de acordo com a EVA dentre os 121 convocados. Durante seis semanas os doentes elegíveis foram submetidos a tratamento farmacológico e fisioterápico padronizado. Sete doentes usufruíram melhora clínica importante e oito abandonaram o estudo, restando 31 doentes que participaram efetivamente do estudo. Após a randomização, 14 doentes foram submetidos a TOC com cabeçote ativo e 17 a TOC com cabeçote placebo. Foram avaliados os aspectos demográficos, a apresentação clínica, a incapacidade funcional, a intensidade e as características da dor até um ano após a realização dos procedimentos destes 31 doentes. As avaliações foram realizadas com uso da Escala Visual Analógica (EVA), Questionário de Incapacidade de Roland-Morris (RDQ), Índice de Incapacidade de Oswestry (ODI), Versão Reduzida do Questionário de Dor McGill (SF-MPQ) e Inventário Diagnóstico da Dor Neuropática 4 (DN4). RESULTADOS: Não houve diferenças estatisticamente significativas entre os grupos quanto às características sociodemográficas dos doentes. Entretanto, a duração das queixas de dor dos doentes do grupo TOC ativo foi significativamente superior (p < 0,05) a dos do grupo TOC placebo. Em relação aos doentes tratados com TOC placebo, os doentes tratados com TOC ativo usufruíram redução estatisticamente significativa da dor de acordo com a EVA na interação grupo versus tempo a partir do momento \"três meses\"; a melhora manteve-se estatisticamente significativa durante um ano (p < 0,001), achado que sugere que o efeito analgésico instala-se em longo prazo e mantém-se prolongadamente. Não ocorreu modificação estatisticamente significativa na interação grupo versus tempo nas pontuações dos questionários RDQ, ODI e SF-MPQ ao longo do tempo nos doentes de ambos grupos. No momento \"12 meses\" ocorreu redução superior a 50% da incapacidade funcional da dor lombar avaliada de acordo com o RDQ em 70,0% dos doentes do grupo TOC ativo e em apenas 14,3% dos doentes tratados com TOC placebo; diferença percentual estatisticamente significativa (p < 0,05). Ocorreu também redução superior a 50% das pontuações do ODI na avaliação realizada no momento \"12 meses\" em 70,0% dos doentes incluídos no grupo TOC ativo e em apenas 14,3% dos doentes do grupo TOC placebo, diferença percentual estatisticamente significativa (p < 0,05). CONCLUSÕES: O tratamento com o TOC ativo dos doentes com SDM nas regiões lombar e glútea proporcionou melhora significativa da dor a partir do momento \"três meses\" até, pelo menos, o momento \"12 meses\" de acompanhamento, achado que sugere que seu efeito analgésico instala-se tardiamente. Adicionalmente, proporcionou melhora da funcionalidade de acordo com o RDQ e ODI na avaliação realizada no momento \"12 meses\" / INTRODUCTION: Extracorporeal shockwave therapy (ESWT) has been used successfully in different musculoskeletal conditions, including pseudarthrosis and tendinopathies. However, there are very few well-structured studies on the efficacy of ESWT in the treatment of myofascial pain syndromes (MPSs) and no randomized clinical trial about the ESWT in the treatment of lumbar and gluteal myofascial pain. OBJECTIVES: To assess the efficacy of ESWT in the treatment of lumbar and gluteal MPSs. MATERIAL AND METHODS: The study was prospective, randomized, double-blind and placebo-controlled. From 121 patients with moderate or severe pain due to MPS in the lumbar and gluteal regions lasting more than six months were enrolled; a total of 46 patients with pain intensity >= 4 according to the VAS were considered eligible. The elected patients were treated with antidepressant, analgesic and physical therapy as a standard protocol during six weeks. Seven patients had significant clinical improvement with the pharmacological and physical therapies and eight dropped out the study. The remainder 31 patients were randomized and 14 underwent active ESWT and 17 underwent placebo ESWT. The demographic aspects, clinical presentations, functional disabilities, severity and characteristics of pain were evaluated previously to the inclusion in the study until the end of the first year after the treatment with active or placebo ESWT. The evaluations were based on the Visual Analogue Scale (VAS), Roland- Morris Disability Questionnaire (RDQ), Oswestry Disability Index (ODI), Short- Form of the McGill Pain Questionnaire (SF-MPQ), and the Neuropathic Pain Diagnostic Questionnaire 4 (DN4). RESULTS: There were no statistical differences between the groups regarding the baseline characteristics of the patients. However, the duration of pain of the patients treated with active ESWT was significantly higher (p < 0,05) than those treated with placebo ESWT. There was no statistically significant variation over time in the RDQ, ODI and SF-MPQ scores between the patients from each group. Patients treated with active ESWT presented a significant reduction of pain severity according to the VAS from the third until the 12nd month of follow-up (p < 0,001), finding indicative that the analgesic effect of the ESWT starts late but remains over time. At the 12nd month of follow-up, 70,0% of the patients treated with active ESWT and just 14.3% of the patients from de placebo ESWT group had more than 50% improvement of the functional disability of the low back pain according to the RDQ, statistically significant difference (p < 0,05). There was also a reduction of more than 50% of ODI scores in the 12th month of follow-up in 70.0% of the patients treated with active ESWT and in only 14.3% of the patients treated with placebo ESWT (p < 0,05). CONCLUSIONS: The active ESWT provided a significant and lasting reduction in pain intensity from the third until the 12th month of follow-up, finding that suggests that its analgesic effect settles late and has long duration. Additionally, it provided improvement of the functionality according to the RDQ and ODI at the 12th month of follow-up

The prevalence of low back pain (LBP) is higher in pregnant women compared to women of the same age in a general population. Pregnancy-related LBP persists 6 years after pregnancy in 16% of women. Consequently, pregnancy represents a specific risk for LBP and persistent LBP. Pregnancy-related LBP is usually studied as a single entity, however, only one subgroup of LBP, i.e. pelvic girdle pain (PGP), seems to be associated with pregnancy. Accordingly, possible differences in subgroups of patients with LBP are unknown. The aims of this thesis were the following: 1) to describe the prevalence of clinically classified subgroups of women with LBP in a cohort (no LBP, lumbar pain, PGP, and combined pain (PGP and lumbar pain)) during pregnancy and postpartum, and 2) to determine if there was a disparity in the course, health-related quality of life (HRQL), pain intensity, disability, depressive symptoms, or muscle function in subgroups of the cohort, and 3) to identify predictors for having persistent pregnancy-related PGP postpartum. Consecutively-enrolled pregnant women were classified into LBP subgroups by mechanical assessment of the lumbar spine, pelvic pain provocation tests, standard history, and pain drawings. All women answered questionnaires (background data, EQ-5D). Women with LBP completed the Oswestry Disability Index and pain measures. The Edinburgh Postnatal Depression Scale was used to evaluate depressive symptoms at 3 months postpartum (cut-off ≥10). Trunk muscle endurance, hip muscle strength, and gait speed were investigated. Multiple logistic regression was used to identify predictors from self-reports and clinical examination. At the 12-18 gestational week evaluation, 118/308 (38%) women had no LBP, 33 (11%) had lumbar pain, 101 (33%) had PGP, and 56 (18%) had combined pain. Three months postpartum, 183/272 (67%) women had no LBP, 29 (11%) had lumbar pain, 46 (17%) had PGP, and 14 (5%) had combined pain. Pregnant women with combined pain were most affected in terms of HRQL, pain intensity, and disability. Depressive symptoms were three times more prevalent in women with LBP (27/87, 31%) than in women without LBP (17/180, 9%). Women with PGP and/or combined pain had lower values for trunk muscle endurance, hip extensor strength and gait speed compared to women without LBP. Postpartum, 16-20% of the women had persistent combined pain or PGP, whereas 1/29 had lumbar pain. Predictors for persistent PGP or combined pain were work dissatisfaction, older age, combined pain in early pregnancy, and low endurance of the back flexors. In conclusion, women with combined pain were identified to be a target group since they had the lowest recovery rate and since the classification of combined pain was found to be a predictor for persistent PGP or combined pain postpartum. The hypothesis of an association between muscle dysfunction and PGP was strengthened. Based on the finding of high comorbidity of postpartum depressive symptoms and LBP, it seems important to screen for and consider treatment strategies for both symptoms.

Chronic pain sufferers are frequently misunderstood and stigmatised. The aim of this investigation was to provide a description of the lifewor1d of people with chronic low back pain, using the phenomenological method. Themes which emerged were that the persistent nature of chronic pain makes it particularly difficult to endure, arousing a profound fear of the future. It causes a disruption in the relationship between the person and the body, in which the person is forced to function within the constraints of pain. Sufferers are unable to fulfil social roles as expected and are forced to revise their goals and activities. The distress of their experience is mediated by the ability to make sense of their condition, finding meaning in the pain itself. The study highlights the value of the phenomenological method in health psychology. Recommendations are made which may be of benefit to people with chronic pain and their families. / Psychology / M. Sc. (Psychology)

Objective : Low back pain (LBP), and in particular sacroiliac joint syndrome, is a significant health concern for both patient and their chiropractor with regards to quality of life and work related musculoskeletal disorders. Therefore, chiropractors often utilise mechanical aids to reduce the impact on the chiropractor’s health. It is, however, important to establish whether these mechanical aids are indeed clinically effective, therefore, this study evaluated the Activator Adjusting Instrument (AAI) against an AAI placebo to determine whether this adjusting instrument is an effective aid for both the chiropractor and the patient. Method : This randomised, placebo controlled clinical trial consisted of 40 patients (20 per group), screened by stringent inclusion criteria assessed through a telephonic and clinical assessment screen. Post receipt of informed consent from the patients, measurements (NRS, Revised Oswestry Disability Questionnaire, algometer) were taken at baseline, prior to consultation three and at the follow consultation. This procedure occurred with four interventions over a two week period. Results: The AAI group showed clinical significance for all clinical measures as compared to the AAI placebo group which attained clinical significance only for the Revised Oswestry Disability Questionnaire. By comparison there was only a statistically significant difference between the groups in terms of the algometer readings (p= 0.037). Conclusion : Therefore, it is evident that the AAI seems to have clinical benefit beyond a placebo. However this is not reflected in the statistical analysis. It is, therefore, suggested that this study be repeated with a larger sample size in order to verify the effect on the statistical analysis outcomes.

Submitted in partial compliance with the requirements for the Master’s Degree in Technology: Chiropractic, Durban University of Technology, 2014. / Flexion distraction chiropractic technique (FDCT) is a commonly used manual therapy technique which is purported to address various clinical pain syndromes. However, it lacks the credibility of appropriate evidence-based guidelines. An analysis of the literature would be able to inform the development of guidelines. Objectives: The aim of this systematic review was to determine the evidence to support the use of FDCT in clinical practice. Data sources: A systematic review of PubMed and Summons was conducted, using the following search terms: chiropractic, flexion distraction, protocol and / or technique. Study selection: All electronic or paper, English articles, which possessed the required key indexing terms and represented randomised and non-randomised controlled study designs were included. Data extraction: Blinded review of the articles was conducted by three independent reviewers utilising the PEDro (for randomised controlled trials) and NOS for (non-randomised controlled trials). This allowed the methodological rigour of the article to be ranked. This ranking was compared to a critical appraisal of the article in order to achieve an overall decision with regards to the contribution of the article to the level of evidence for FDCT. Data synthesis: 18 review outcomes were aggregated around four clinical categories; two articles each on neck pain, chronic pelvic pain, and physiological outcomes and the remaining twelve on low back pain. There was agreement that the evidence for pelvic pain and physiological function was limited to no evidence and limited respectively. Conflicting evidence existed for neck and low back pain (single and multimodal treatment) with limited and moderate evidence respectively. Conclusion: FDCT is clinically advocated for many conditions. The evidence provided in this review indicates that practitioners should be guarded in their use of FDCT, as the evidence to its widespread use is limited to only those conditions noted in this review. Therefore, further high quality and rigorous studies are required to develop appropriate treatment guidelines for use by practitioners to adequately provide evidence based care in clinical practice.

This study deals with the complex phenomenon of occupational health. There is knowledge of how a good work environment should look like, but despite this, many employees experiences ill health in the workplace mainly in the form of neck and back pain. This study is a case study conducted in a high-risk workplace. The overall purpose was to describe and analyze the health situation of a specific company with neck and back problems. Mainly, eight interviews had been used as the data collection method, but additional observations had also been implemented. The sources used in this study are mainly reports of health, work environment, health promotion activities and neck and back pain. The results of this study showed that there are shortcomings in the work environment and they often experiences high levels of stress, but despite this, the employees thrived at work. The employees had a relatively good health despite the fact that all the interviewees indicated that they had some form of neck and back pain. The results also showed that the most important conditions to promote health were motivation, time, and healthcare in the workplace.

Introduction: Baggage handling is considered to be a heavy manual handling job including biomechanical exposures suspected of increasing the risk for musculoskeletal disorders. Aims: To document low back pain (LBP), shoulder pain (SP), and physical and psychosocial factors in baggage handlers, and to evaluate the implementation of an ergonomic intervention aiming to increase the use of loading assist devices. Methods: A questionnaire was utilized to characterize pain and psychosocial work conditions in 525 baggage handlers. The postures of 55 baggage handlers during 114 shifts were measured using inclinometry, half shift video-recordings were made for subsequent task analysis, and the number of aircraft handled was registered. Associations for psychosocial and biomechanical exposures with pain were assessed using regression analyses. An ergonomic intervention was implemented and evaluated using questionnaires and repeated interviews. Feasibility, intermediate outcomes, barriers and facilitators were assessed. Results: The prevalence rates of reported LBP and SP were 70% and 60%, respectively. Pain interfering with work (LBP - 30% and SP - 18%) and high pain intensity (LBP - 34% and SP - 28%) were associated with poor psychosocial working conditions. Extreme postures with arms elevated &gt;60° occurred for 6.4% of the total time, and in trunk flexion &gt;60° for 2.1% total time. In contrast, 71% of the total time was spent in a neutral trunk posture. The 90th percentile trunk forward flexion was 34.1°.  Daily shoulder pain increased in approximately one-third of all shifts and was positively associated with extreme work posture and the number of aircraft handled; this association was modified by influence and support. The intervention was delivered as planned, and dose received and satisfaction were rated as high. Motivated trainees facilitated implementation while lack of manager support, opportunities to observe and practice behaviors, follow-up activities, staff reduction, and job insecurity were barriers. Conclusion: The high prevalence rates of LBP and SP in baggage handlers were associated with psychosocial exposures, and daily shoulder pain was associated with higher biomechanical exposure. Barriers to implementation can be minimized by recruiting motivated trainees, securing strong organizational support, and carrying out follow-up activities.

The disabling conditions of chronic low-back pain continue to cost patient, family, and society. The intricate mechanisms which perpetuate this medical condition often consist of both organic and functional factors. This study evaluated personality and psychosocial variables which may control individual responses to facet denervation, a treatment for chronic lumbar distress. The subjects were 47 chronic pain patients whose symptoms conformed to the facet syndrome. Patient responses to the Minnesota Multiphasic Personality Inventory (MMPI) and the Sixteen Personality Factor Questionnaire were reviewed in an effort to predict statistically symptomatic relief. Also, the patients' involvement in litigation and their accuracy in determining their pain level were studied as possible influencing variables. Results show the litigation factor and two scalesof the MMPI to be most useful in predicting patient response from facet denervation treatment.

Mémoire numérisé par la Division de la gestion de documents et des archives de l'Université de Montréal.